0001317757-12-000003.txt : 20120104
0001317757-12-000003.hdr.sgml : 20120104
20120104164138
ACCESSION NUMBER: 0001317757-12-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120103
FILED AS OF DATE: 20120104
DATE AS OF CHANGE: 20120104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White Christopher G
CENTRAL INDEX KEY: 0001537668
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 12506718
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2012-01-03
0
0000792977
AMAG PHARMACEUTICALS INC.
AMAG
0001537668
White Christopher G
C/O AMAG PHARMACEUTICALS, INC.
100 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Business Officer and SVP
Restricted Stock Units
2012-01-03
4
A
0
20000
A
Common Stock
20000
20000
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This grant vests as follows: 50% on January 3, 2013, 25% on January 3, 2014 and the remaining 25% on January 3, 2015.
Not applicable.
Joseph L. Farmer, attorney-in-fact
2012-01-04